Immune Thrombocytopenia (ITP) Immune-Genetic Assessment (UNIT)

Azienda Sanitaria-Universitaria Integrata di Udine

Status: Unknown

Conditions: Thrombocytopenia

Study type: Observational

Funder types: Other

Identifiers

NCT01196884

UNIT

Details and patient eligibility

About

Primary ITP has wide heterogenous biology, presentation and response to therapy.

The immune-genetic assessment of ITP may help to identify differences among patients with ITP and optimize the therapeutic choice.

Enrollment: 190 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Adult patients with primary ITP

Exclusion criteria

• Secondary ITP

Trial design

190 participants in 3 patient groups

Asymptomatic ITP patients

ITP patients treated with Rituximab

ITP patients treated with steroids